The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
1847 GOEDEKER INC *W EXP 99/99/999 28252C117 7,386 6,103,824 SH   SOLE   6,103,824 0 0
89BIO INC COM 282559103 1,934 148,000 SH   SOLE   148,000 0 0
ACHIEVE LIFE SCIENCES INC COM 004468500 949 122,000 SH   SOLE   122,000 0 0
ADICET BIO INC COM 007002108 4,600 263,000 SH   SOLE   263,000 0 0
ADMA BIOLOGICS INC COM 000899104 4,653 3,300,000 SH   SOLE   3,300,000 0 0
AEGLEA BIOTHERAPEUTICS INC COM 00773J103 1,395 293,764 SH   SOLE   293,764 0 0
AGILETHOUGHT INC CLASS A COM 00857F100 225 47,670 SH   SOLE   47,670 0 0
ALPHATEC HLDGS INC COM NEW 02081G201 2,915 255,000 SH   SOLE   255,000 0 0
ARYA SCIENCES ACQU CORP IV CL A G31659108 992 100,000 SH   SOLE   100,000 0 0
AULT DISRUPTIVE TECHS CORP UNIT 99/99/9999 05150A203 1,520 150,000 SH   SOLE   150,000 0 0
AVADEL PHARMACEUTICALS PLC SPONSORED ADR 05337M104 3,560 440,589 SH   SOLE   440,589 0 0
AVIDITY BIOSCIENCES INC COM 05370A108 5,348 225,000 SH   SOLE   225,000 0 0
BCLS ACQUISITION CORP COM CL A G0904B105 980 100,000 SH   SOLE   100,000 0 0
BELLUS HEALTH INC NEW COM NEW 07987C204 11,673 1,450,006 SH   SOLE   1,450,006 0 0
BICYCLE THERAPEUTICS PLC SPONSORED ADS 088786108 10,470 172,000 SH   SOLE   172,000 0 0
BRIDGEBIO PHARMA INC COM 10806X102 906 54,300 SH Call SOLE   54,300 0 0
CARDIFF ONCOLOGY INC COM 14147L108 2,025 337,000 SH   SOLE   337,000 0 0
CELCUITY INC COM 15102K100 1,913 145,000 SH   SOLE   145,000 0 0
CELLDEX THERAPEUTICS INC NEW COM NEW 15117B202 4,869 126,000 SH   SOLE   126,000 0 0
CERUS CORP COM 157085101 3,167 465,000 SH   SOLE   465,000 0 0
CHAVANT CAPITAL ACQUISITN CO ORDINARY SHARES G2058L103 1,968 200,000 SH   SOLE   200,000 0 0
CHAVANT CAPITAL ACQUISITN CO *W EXP 99/99/999 G2058L111 74 150,000 SH   SOLE   150,000 0 0
CHINOOK THERAPEUTICS INC COM 16961L106 8,889 545,000 SH   SOLE   545,000 0 0
CINGULATE INC COMMON STOCK 17248W105 232 83,931 SH   SOLE   83,931 0 0
CINGULATE INC *W EXP 12/03/202 17248W113 192 270,000 SH   SOLE   270,000 0 0
CITIC CAPITAL ACQUISITION CO COM CL A G21513109 1,113 111,200 SH   SOLE   111,200 0 0
COLISEUM ACQUISITION CORP *W EXP 08/22/202 G2263T107 23 28,333 SH   SOLE   28,333 0 0
COLISEUM ACQUISITION CORP CLASS A ORD SHS G2263T123 826 85,000 SH   SOLE   85,000 0 0
COLOMBIER ACQUISITION CORP CL A 19533H108 482 50,000 SH   SOLE   50,000 0 0
COLOMBIER ACQUISITION CORP *W EXP 99/99/999 19533H116 9 16,666 SH   SOLE   16,666 0 0
CONNECT BIOPHARMA HLDGS LTD ADS 207523101 901 175,000 SH   SOLE   175,000 0 0
CONTEXT THERAPEUTICS INC COM 21077P108 1,313 493,531 SH   SOLE   493,531 0 0
CRINETICS PHARMACEUTICALS IN COM 22663K107 9,404 331,000 SH   SOLE   331,000 0 0
CTI BIOPHARMA CORP COM 12648L601 5,419 2,185,000 SH   SOLE   2,185,000 0 0
CURIS INC COM NEW 231269200 3,946 829,000 SH   SOLE   829,000 0 0
CYMABAY THERAPEUTICS INC COM 23257D103 5,915 1,750,000 SH   SOLE   1,750,000 0 0
CYTOMX THERAPEUTICS INC COM 23284F105 2,874 663,800 SH   SOLE   663,800 0 0
DIGITAL HEALTH ACQUISITION C UNIT 11/02/2026 253893200 1,536 150,000 SH   SOLE   150,000 0 0
DOUBLEDOWN INTERACTIVE CO LT ADS 25862B109 944 60,876 SH   SOLE   60,876 0 0
DYNE THERAPEUTICS INC COM 26818M108 1,981 166,636 SH   SOLE   166,636 0 0
EIGER BIOPHARMACEUTICALS INC COM 28249U105 1,355 261,000 SH   SOLE   261,000 0 0
ESPERION THERAPEUTICS INC NE COM 29664W105 12,579 2,515,785 SH   SOLE   2,515,785 0 0
ESSA PHARMA INC COM NEW 29668H708 4,899 345,000 SH   SOLE   345,000 0 0
EUCRATES BIOMEDICAL ACQU COR SHS G3141W106 3,904 400,000 SH   SOLE   400,000 0 0
EUCRATES BIOMEDICAL ACQU COR *W EXP 10/23/202 G3141W122 77 133,333 SH   SOLE   133,333 0 0
EXACT SCIENCES CORP COM 30063P105 3,425 44,000 SH   SOLE   44,000 0 0
EYEPOINT PHARMACEUTICALS INC COM NEW 30233G209 2,754 225,000 SH   SOLE   225,000 0 0
FAT BRANDS INC *W EXP 07/16/202 30258N121 1,533 227,000 SH   SOLE   227,000 0 0
FIRSTMARK HORIZON ACQUISITIO CL A COM 33765Y101 989 100,000 SH   SOLE   100,000 0 0
FLUX PWR HLDGS INC COM NEW 344057302 1,485 346,268 SH   SOLE   346,268 0 0
GIGINTERNATIONAL1 INC *W EXP 04/19/202 37518W114 29 50,000 SH   SOLE   50,000 0 0
GIGINTERNATIONAL1 INC COM 37518W106 1,986 200,000 SH   SOLE   200,000 0 0
GLAUKOS CORP COM 377322102 3,600 81,000 SH   SOLE   81,000 0 0
GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 1,581 54,000 SH   SOLE   54,000 0 0
GLOBUS MED INC CL A 379577208 4,260 59,000 SH   SOLE   59,000 0 0
HARBOR CUSTOM DEVELOPMENT IN *W EXP 05/09/202 41150T116 234 600,000 SH   SOLE   600,000 0 0
HARBOR CUSTOM DEVELOPMENT IN *W EXP 10/04/202 41150T124 501 650,000 SH   SOLE   650,000 0 0
HARBOR CUSTOM DEVELOPMENT IN 8% CONV PFD SR A 41150T207 2,901 185,000 SH   SOLE   185,000 0 0
HEALTH SCIENCES ACQ CORP 2 ORD SHS G4411D109 101 10,000 SH   SOLE   10,000 0 0
HELIUS MED TECHNOLOGIES INC COM CL A NEW 42328V603 254 48,862 SH   SOLE   48,862 0 0
HELIX ACQUISITION CORP COM CL A G4444C102 2,473 250,000 SH   SOLE   250,000 0 0
HILLMAN SOLUTIONS CORP COM 431636109 1,527 142,000 SH   SOLE   142,000 0 0
ICAD INC COM NEW 44934S206 460 63,929 SH   SOLE   63,929 0 0
ILLUMINA INC COM 452327109 6,658 17,500 SH   SOLE   17,500 0 0
IMMATICS N.V SHS N44445109 6,317 469,980 SH   SOLE   469,980 0 0
IMMATICS N.V *W EXP 07/01/202 N44445117 428 97,467 SH   SOLE   97,467 0 0
IMMIX BIOPHARMA INC COM 45258H106 436 122,388 SH   SOLE   122,388 0 0
IMMUNIC INC COM 4525EP101 3,034 317,000 SH   SOLE   317,000 0 0
INDUSTRIAL HUMAN CAPITAL INC *W EXP 11/27/202 45617P112 38 100,000 SH   SOLE   100,000 0 0
INDUSTRIAL HUMAN CAPITAL INC COM 45617P104 992 100,000 SH   SOLE   100,000 0 0
INFUSYSTEM HLDGS INC COM 45685K102 2,980 175,000 SH   SOLE   175,000 0 0
INSMED INC COM PAR $.01 457669307 5,539 203,354 SH   SOLE   203,354 0 0
INSPIRE MED SYS INC COM 457730109 5,291 23,000 SH   SOLE   23,000 0 0
IOVANCE BIOTHERAPEUTICS INC COM 462260100 5,727 300,000 SH Call SOLE   300,000 0 0
IVERIC BIO INC COM 46583P102 5,503 329,101 SH   SOLE   329,101 0 0
JIYA ACQUISITION CORP COM CL A 47760M102 1,954 200,000 SH   SOLE   200,000 0 0
KALEYRA INC COM 483379103 4,356 433,892 SH   SOLE   433,892 0 0
KALVISTA PHARMACEUTICALS INC COM 483497103 1,480 111,834 SH   SOLE   111,834 0 0
KEROS THERAPEUTICS INC COM 492327101 6,787 116,000 SH   SOLE   116,000 0 0
LAKESHORE ACQUISITION I CORP *W EXP 07/15/202 G53521111 116 150,000 SH   SOLE   150,000 0 0
LAKESHORE ACQUISITION I CORP ORDINARY SHARES G53521103 1,972 200,000 SH   SOLE   200,000 0 0
LANTHEUS HLDGS INC COM 516544103 7,858 272,000 SH   SOLE   272,000 0 0
LEGEND BIOTECH CORP SPONSORED ADS 52490G102 2,331 50,000 SH   SOLE   50,000 0 0
MADRIGAL PHARMACEUTICALS INC COM 558868105 2,034 24,000 SH   SOLE   24,000 0 0
MDXHEALTH SA SPONSORED ADS 58286E102 344 36,159 SH   SOLE   36,159 0 0
MORPHIC HLDG INC COM 61775R105 2,843 60,000 SH   SOLE   60,000 0 0
MOTIVE CAPITAL CORP SHS CL A G6293A103 1,005 102,099 SH   SOLE   102,099 0 0
MUSCLE MAKER INC COM 627333107 1,437 1,995,882 SH   SOLE   1,995,882 0 0
MY SIZE INC COM NEW 62844N208 210 416,589 SH   SOLE   416,589 0 0
MYRIAD GENETICS INC COM 62855J104 5,244 190,000 SH   SOLE   190,000 0 0
NANOSTRING TECHNOLOGIES INC COM 63009R109 6,187 146,500 SH   SOLE   146,500 0 0
NATERA INC COM 632307104 3,269 35,000 SH   SOLE   35,000 0 0
NEVRO CORP COM 64157F103 3,405 42,000 SH   SOLE   42,000 0 0
NEXGEL INC *W EXP 12/01/202 65344E115 182 225,000 SH   SOLE   225,000 0 0
NEXGEL INC COM 65344E107 75 28,570 SH   SOLE   28,570 0 0
NLS PHARMACEUTICS LTD *W EXP 09/25/202 H57830111 146 200,000 SH   SOLE   200,000 0 0
NOCTURNE ACQUISITION CORP RIGHT 12/26/2025 G6580S106 200 500,000 SH   SOLE   500,000 0 0
NOCTURNE ACQUISITION CORP ORDINARY SHARES G6580S114 5,000 500,000 SH   SOLE   500,000 0 0
OCULAR THERAPEUTIX INC COM 67576A100 4,844 695,000 SH   SOLE   695,000 0 0
OMEGA ALPHA SPAC CL A G6749V107 977 100,000 SH   SOLE   100,000 0 0
OPY ACQUISITION CORP I UNIT 09/22/2026 671005205 1,000 100,000 SH   SOLE   100,000 0 0
PALISADE BIO INC COM 696389105 434 333,954 SH   SOLE   333,954 0 0
PARDES BIOSCIENCES INC COM 69945Q105 3,274 200,000 SH   SOLE   200,000 0 0
PEPPERLIME HEALTH ACQUSTN CO CLASS A ORD SHS G70021103 7,203 735,000 SH   SOLE   735,000 0 0
PEPPERLIME HEALTH ACQUSTN CO *W EXP 10/01/202 G70021111 165 367,500 SH   SOLE   367,500 0 0
PROFOUND MED CORP COM NEW 74319B502 3,369 300,000 SH   SOLE   300,000 0 0
PROTAGONIST THERAPEUTICS INC COM 74366E102 11,833 346,000 SH   SOLE   346,000 0 0
QIAGEN NV SHS NEW N72482123 5,169 93,000 SH   SOLE   93,000 0 0
QUIDEL CORP COM 74838J101 4,995 37,000 SH   SOLE   37,000 0 0
RELMADA THERAPEUTICS INC COM 75955J402 4,641 206,000 SH   SOLE   206,000 0 0
RENOVACOR INC COM 75989E106 2,994 388,845 SH   SOLE   388,845 0 0
RENOVACOR INC *W EXP 99/99/999 75989E114 417 731,561 SH   SOLE   731,561 0 0
REPRO MED SYS INC COM 759910102 2,987 995,500 SH   SOLE   995,500 0 0
RESERVOIR MEDIA INC *W EXP 08/26/202 76119X113 70 50,000 SH   SOLE   50,000 0 0
REZOLUTE INC COM NEW 76200L309 1,099 230,000 SH   SOLE   230,000 0 0
SARISSA CAPITAL ACQUISITN CO CL A G7823W102 2,203 225,000 SH   SOLE   225,000 0 0
SARISSA CAPITAL ACQUISITN CO *W EXP 10/23/202 G7823W110 71 75,000 SH   SOLE   75,000 0 0
SIENTRA INC COM 82621J105 3,178 866,000 SH   SOLE   866,000 0 0
STAAR SURGICAL CO COM PAR $0.01 852312305 2,374 26,000 SH   SOLE   26,000 0 0
STRYVE FOODS INC CLASS A COM 863685103 640 162,121 SH   SOLE   162,121 0 0
SURGEPAYS INC *W EXP 10/22/202 86882L113 161 250,000 SH   SOLE   250,000 0 0
SURROZEN INC *W EXP 08/01/203 86889P117 95 82,233 SH   SOLE   82,233 0 0
SYROS PHARMACEUTICALS INC COM 87184Q107 3,782 1,160,000 SH   SOLE   1,160,000 0 0
TAILWIND ACQUISITION CORP COM CL A 87403Q102 1,264 128,414 SH   SOLE   128,414 0 0
TG VENTURE ACQUISITION CORP UNIT 08/15/2028 87251T208 2,050 200,000 SH   SOLE   200,000 0 0
TRAVERE THERAPEUTICS INC COM 89422G107 4,377 141,000 SH   SOLE   141,000 0 0
TURMERIC ACQUISITION CORP *W EXP 10/08/202 G9127T124 51 84,666 SH   SOLE   84,666 0 0
TURMERIC ACQUISITION CORP CL A G9127T108 2,494 254,000 SH   SOLE   254,000 0 0
UPHEALTH INC *W EXP 06/08/202 91532B119 3 10,000 SH   SOLE   10,000 0 0
VERASTEM INC COM 92337C104 4,619 2,253,000 SH   SOLE   2,253,000 0 0
VERRICA PHARMACEUTICALS INC COM 92511W108 897 97,887 SH   SOLE   97,887 0 0
VIQ SOLUTIONS INC COM NEW 91825V400 1,642 704,687 SH   SOLE   704,687 0 0
XTANT MED HLDGS INC COM NEW 98420P308 3,498 6,246,291 SH   SOLE   6,246,291 0 0